In Vivo and In Vitro Characterization of a Novel Neuroprotective Strategy for Stroke: Ischemic Postconditioning
Open Access
- 19 September 2007
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 28 (2) , 232-241
- https://doi.org/10.1038/sj.jcbfm.9600559
Abstract
As clinical trials of pharmacological neuroprotective strategies in stroke have been disappointing, attention has turned to the brain's own endogenous strategies for neuroprotection. Recently, a hypothesis has been offered that modified reperfusion subsequent to a prolonged ischemic episode may also confer ischemic neuroprotection, a phenomenon termed ‘postconditioning’. Here we characterize both in vivo and in vitro models of postconditioning in the brain and offer data suggesting a biological mechanism for protection. Postconditioning treatment reduced infarct volume by up to 50% in vivo and by ∼30% in vitro. A duration of 10 mins of postconditioning ischemia after 10 mins of reperfusion produced the most effective postconditioning condition both in vivo and in vitro. The degree of neuroprotection after postconditioning was equivalent to that observed in models of ischemic preconditioning. However, subjecting the brain to both preconditioning as well as postconditioning did not cause greater protection ...Keywords
This publication has 49 references indexed in Scilit:
- The Changes in Endogenous Antioxidant Enzyme Activity After PostconditioningCellular and Molecular Neurobiology, 2006
- Delayed Postconditionig Initiates Additive Mechanism Necessary for Survival of Selectively Vulnerable Neurons After Transient Ischemia in Rat BrainCellular and Molecular Neurobiology, 2006
- Post‐conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential neuroprotective treatmentEuropean Journal of Neuroscience, 2005
- Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2American Journal of Physiology-Heart and Circulatory Physiology, 2005
- Future Targets and Cascades for Neuroprotective StrategiesStroke, 2004
- Suppression of Endogenous bcl-2 Expression by Antisense Treatment Exacerbates Ischemic Neuronal DeathJournal of Cerebral Blood Flow & Metabolism, 2000
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- Graded Postischemic Reoxygenation Ameliorates Inhibition of Cerebral Cortical Protein Synthesis in DogsJournal of Cerebral Blood Flow & Metabolism, 1991
- Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.Stroke, 1986
- Prolonged anoxic survival due to anoxia pre-exposure: brain ATP, lactate, and pyruvateAmerican Journal of Physiology-Legacy Content, 1964